Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 18.5M | 16.2M | 16.6M | 18.0M |
| Cost of revenue | 5.6M | 5.4M | 4.6M | 6.1M |
| Gross profit | 12.8M | 10.8M | 12.0M | 11.9M |
| Operating expense | ||||
| Research & development | 162K | 522K | 426K | 1.0M |
| Selling general and admin | 9.3M | 9.7M | 10.8M | 11.1M |
| Other operating expenses | — | — | — | — |
| Operating income | 2.4M | -378K | -146K | -1.5M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 900K | 1.1M | 994K | — |
| Other income expense | 2.3M | 1.8M | 2.6M | 2.4M |
| Pretax income | 3.8M | 382K | 1.5M | -3.9M |
| Tax provision | -122K | -283K | 405K | 695K |
| Net income | 4.0M | 788K | 1.5M | -4.6M |
| Basic EPS | 0.7 | 0.1 | 0.2 | — |
| Diluted EPS | 0.2 | -0.3 | -0.2 | — |
| Basic average shares | 6.1M | 6.1M | 6.1M | — |
| Diluted average shares | 8.2M | 8.5M | 9.1M | — |
| EBITDA | 3.9M | 935K | 1.8M | -4.7M |
| Net income from continuing op. | 4.0M | 788K | 1.5M | -4.6M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |